首页> 外文期刊>Journal of Drug Delivery and Therapeutics >Formulation, Development and Evaluation of Transfersomal Gel of Metronidazole
【24h】

Formulation, Development and Evaluation of Transfersomal Gel of Metronidazole

机译:甲硝唑传递体凝胶的研制,开发与评价

获取原文
           

摘要

Metronidazole?is an antibiotic that is used to treat a wide variety of infections. It works by stopping the growth of certain bacteria and parasites . This antibiotic treats only certain bacterial and parasitic infections. It may also be used with other medications to treat certain?stomach/intestinal ulcers caused by bacteria (H. pylori). A transferosome is the first generation of an elastic liposome prepared from phospholipids and edge activators. An edge activator is often a single-chain surfactant with a high radius of curvature that destabilizes the lipid bilayers of vesicles and increases the deformability of the bilayers, thereby making the vehicle ultra-deformable. The aim of the present study was to investigate the potential of transfersomal gel formulations for transdermal delivery of metronidazole and to evaluate the effect of lipid concentration, ethanol concentration, drug concentration and stirrer time. Characterization of transfersomes performed by vesicle size, surface charge, entrapment efficiency and zeta potential. Characterization of transfersome containing gel performed by the measurement of viscosity, drug content, extrudability study, spreadability and in vitro drug diffusion study. It was found that viscosity of prepared gel was 3560cps, % assay was 98.89±0.45, extrudability was 1156g and spreadibility (g.cm/sec) was found that 11.23(g.cm/sec) respectively . In vitro drug release from transfersomes gel was carried out using Franz diffusion cell method and found 85.56% in 12 hr. In first 30 min it was 22.2 % drug release which slightly high. It was due to the release of free drug present in bag after leaching from transfersomes. Drug release from transferosomal gel formulation was found in very sustained and controlled manner. The results were obtained which showed that transfersomal gel was a promising candidate for transdermal delivery with targeted and prolonged release of a drug. It also enhances skin permeation of many drugs.
机译:甲硝唑是一种用于治疗多种感染的抗生素。它通过阻止某些细菌和寄生虫的生长而起作用。这种抗生素仅能治疗某些细菌和寄生虫感染。它也可以与其他药物一起使用,以治疗由细菌(幽门螺杆菌)引起的某些胃/肠溃疡。转运体是由磷脂和边缘活化剂制备的第一代弹性脂质体。边缘活化剂通常是具有高曲率半径的单链表面活性剂,其使囊泡的脂质双层失去稳定性并增加双层的可变形性,从而使媒介物超可变形。本研究的目的是研究透体凝胶制剂对甲硝唑透皮给药的潜力,并评估脂质浓度,乙醇浓度,药物浓度和搅拌时间的影响。通过囊泡大小,表面电荷,包封效率和ζ电势对传递体进行表征。通过测量粘度,药物含量,可挤出性研究,铺展性和体外药物扩散研究,对含有传递体的凝胶进行表征。发现制备的凝胶的粘度为3560cps,%测定为98.89±0.45,可挤出性为1156g,铺展性(g.cm/sec)分别为11.23(g.cm/sec)。使用Franz扩散池方法从转移体凝胶中进行体外药物释放,发现在12小时内达到85.56%。在最初的30分钟内,药物释放率为22.2%,略高。这是由于从传递体浸出后袋中游离药物的释放。发现从转运体凝胶制剂释放的药物非常持续和受控。获得的结果表明,传递体凝胶是靶向和延长释放药物的透皮递送的有前途的候选者。它还可以增强许多药物的皮肤渗透性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号